Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma

Author:

Lechner Matt,Takahashi Yoko,Turri-Zanoni Mario,Liu JacklynORCID,Counsell Nicholas,Hermsen MarioORCID,Kaur Raman Preet,Zhao Tianna,Ramanathan Murugappan,Schartinger Volker H.,Emanuel Oscar,Helman Sam,Varghese Jordan,Dudas JozsefORCID,Riechelmann HerbertORCID,Sprung Susanne,Haybaeck JohannesORCID,Howard David,Engel Nils Wolfgang,Stewart Sarah,Brooks Laura,Pickles Jessica C.ORCID,Jacques Thomas S.ORCID,Fenton Tim R.ORCID,Williams Luke,Vaz Francis M.,O'Flynn Paul,Stimpson Paul,Wang Simon,Hannan S. Alam,Unadkat Samit,Hughes Jonathan,Dwivedi Raghav,Forde Cillian T.ORCID,Randhawa Premjit,Gane SimonORCID,Joseph Jonathan,Andrews Peter J.,Royle Gary,Franchi AlessandroORCID,Maragliano RobertaORCID,Battocchio Simonetta,Bewicke-Copley Helen,Pipinikas Christodoulos,Webster AmyORCID,Thirlwell Chrissie,Ho Debbie,Teschendorff Andrew,Zhu TianyuORCID,Steele Christopher D.,Pillay NischalanORCID,Vanhaesebroeck BartORCID,Mohyeldin Ahmed,Fernandez-Miranda Juan,Park Ki Wan,Le Quynh-Thu,West Robert B.,Saade Rami,Manes R. Peter,Omay Sacit Bulent,Vining Eugenia M.,Judson Benjamin L.,Yarbrough Wendell G.,Sansovini MaddalenaORCID,Silvia NicoliniORCID,Grassi IlariaORCID,Bongiovanni AlbertoORCID,Capper David,Schüller Ulrich,Thavaraj SelvamORCID,Sandison Ann,Surda PavolORCID,Hopkins Claire,Ferrari MarcoORCID,Mattavelli DavideORCID,Rampinelli Vittorio,Facchetti Fabio,Nicolai Piero,Bossi PaoloORCID,Henriquez Oswaldo A.,Magliocca Kelly,Solares C. Arturo,Wise Sarah K.,Llorente Jose L.,Patel Zara M.ORCID,Nayak Jayakar V.,Hwang Peter H.ORCID,Lacy Peter D.,Woods RobbieORCID,O'Neill James P.,Jay Amrita,Carnell DawnORCID,Forster Martin D.,Ishii Masaru,London Nyall R.ORCID,Bell Diana M.,Gallia Gary L.,Castelnuovo Paolo,Severi StefanoORCID,Lund Valerie J.ORCID,Hanna Ehab Y.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference41 articles.

1. Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data;Turner;Head Neck,2012

2. Olfactory neuroblastoma;Thompson;Head Neck Pathol,2009

3. Prognostic factors and outcomes of multimodality treatment in olfactory neuroblastoma;Song;Oral Oncol,2020

4. Chemotherapy in esthesioneuroblastoma/olfactory neuroblastoma: an analysis of the surveillance epidemiology and end results (SEER) 1973-2015 database;Cranmer;Am J Clin Oncol Cancer Clin Trials,2020

5. Comparing Kadish, TNM, and the modified Dulguerov staging systems for esthesioneuroblastoma;Joshi;J Surg Oncol,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3